Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

MicroRNAs01:22

MicroRNAs

21.1K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
21.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Discovery of a small molecule TLR3 agonist adjuvant.

Nature communications·2025
Same author

Deep phenomics of PRR agonist activated human blood.

Journal of immunology (Baltimore, Md. : 1950)·2025
Same author

Incorporating meningeal immunity into vaccine development.

Nature communications·2025
Same author

Nanomedicine and Spleen-Targeting Strategies for Precision Immunomodulation: Advances, Challenges, and Future Perspectives.

ACS nano·2025
Same author

OMIP-111: Immune-Profiling of T Helper 1 (Th1), Th2, and Th17 Signatures in Murine Splenocytes by Targeting Intracellular Cytokines.

Cytometry. Part A : the journal of the International Society for Analytical Cytology·2025
Same author

Product and trial design considerations on the path towards a vaccine to combat opioid overdose.

NPJ vaccines·2025

Related Experiment Video

Updated: May 23, 2025

Systemic Delivery of MicroRNA Using Recombinant Adeno-associated Virus Serotype 9 to Treat Neuromuscular Diseases in Rodents
06:51

Systemic Delivery of MicroRNA Using Recombinant Adeno-associated Virus Serotype 9 to Treat Neuromuscular Diseases in Rodents

Published on: August 10, 2018

7.6K

mRNA vaccines: miRNA-based controlled biodistribution and directed adjuvantation.

Byron Brook1, Morgan Goetz1, Valerie Duval2

  • 1Precision Vaccines Program, Boston Children's Hospital, Boston, MA 02115, USA; Harvard Medical School, Boston, MA 02115, USA.

Trends in Immunology
|April 23, 2025
PubMed
Summary

Ionizable lipid nanoparticles (mRNA-LNPs) enabled COVID-19 mRNA vaccines. Future mRNA vaccines can improve by optimizing LNP delivery, transcript control, and adjuvantation for enhanced efficacy and safety.

Keywords:
adjuvantsbiodistributionmRNA vaccinesmicroRNA

More Related Videos

A Simple Alternative to Stereotactic Injection for Brain Specific Knockdown of miRNA
06:53

A Simple Alternative to Stereotactic Injection for Brain Specific Knockdown of miRNA

Published on: December 26, 2015

12.6K
MicroRNA-based Regulation of Picornavirus Tropism
09:05

MicroRNA-based Regulation of Picornavirus Tropism

Published on: February 6, 2017

7.5K

Related Experiment Videos

Last Updated: May 23, 2025

Systemic Delivery of MicroRNA Using Recombinant Adeno-associated Virus Serotype 9 to Treat Neuromuscular Diseases in Rodents
06:51

Systemic Delivery of MicroRNA Using Recombinant Adeno-associated Virus Serotype 9 to Treat Neuromuscular Diseases in Rodents

Published on: August 10, 2018

7.6K
A Simple Alternative to Stereotactic Injection for Brain Specific Knockdown of miRNA
06:53

A Simple Alternative to Stereotactic Injection for Brain Specific Knockdown of miRNA

Published on: December 26, 2015

12.6K
MicroRNA-based Regulation of Picornavirus Tropism
09:05

MicroRNA-based Regulation of Picornavirus Tropism

Published on: February 6, 2017

7.5K

Area of Science:

  • Biotechnology
  • Vaccine Development
  • Nanomedicine

Background:

  • Ionizable lipid nanoparticles (mRNA-LNPs) are crucial for mRNA vaccine delivery, enabling the success of COVID-19 vaccines like BNT162b2 and mRNA-1273.
  • The clinical translation of mRNA vaccines highlights the importance of advanced delivery systems.

Purpose of the Study:

  • To explore rational improvements for mRNA vaccines.
  • To focus on strategies for enhancing mRNA vaccine performance through delivery system modifications and precision targeting.

Main Methods:

  • Discussing LNP modifications for controlled mRNA-LNP biodistribution.
  • Investigating microRNA (miRNA)-based control of encoded transcript biodistribution.
  • Exploring precision adjuvantation strategies.

Main Results:

  • The abstract does not contain specific results, but outlines areas for future research and development.
  • Focus on LNP modifications, miRNA-based transcript control, and precision adjuvantation.

Conclusions:

  • Optimizing LNP properties and incorporating miRNA-based and adjuvantation strategies can lead to next-generation mRNA vaccines.
  • Further research into these areas promises to enhance vaccine efficacy, safety, and targeted delivery.